Search results
CPRIT approved for more than $50M in grants for cancer research
KXAN via Yahoo News· 2 weeks agoOn Wednesday, the governing body for the Cancer Prevention and Research Institute of Texas (CPRIT)...
$63M grant funds OK’d to bring cancer research, treatment to Texas
KXAN via Yahoo News· 7 months agoThe oversight committee of the Cancer Prevention and Research Institute of Texas (CPRIT) approved...
UT researchers receive more than $8M for cancer prevention and more
KXAN via Yahoo News· 3 months agoAUSTIN (KXAN) — Cancer patients across Texas may soon have better access to detection screening and...
Biodexa gains license for polyposis asset as stock more than doubles
Pharmaceutical Technology via Yahoo Finance· 1 month agoUK-based biopharma company Biodexa has entered into an exclusive licencing agreement with Emtora...
Why Are Plus Therapeutics Shares Gaining Today?
Benzinga via Yahoo Finance· 2 years agoPlus Therapeutics Inc (NASDAQ: PSTV) has finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas (CPRIT) for its...
Plus Therapeutics Presents Cancer Treatment Data at Conference
Exec Edge via Yahoo Finance· 9 months agoBy Daniella Parra Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company...
UT institutions receive $65.4M for cancer research
Odessa American, Texas via Yahoo News· 1 year agoFeb. 21—AUSTIN — The Cancer Prevention and Research Institute of Texas (CPRIT) last week awarded nine University of Texas institutions 37 grants totaling $65.4 million. "For UT institutions ...
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoPlus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript October 31, 2023 Operator:...
Plus Therapeutics: Targeting Brain Cancer with Rifle-Shot Precision
IPO-Edge.com via Yahoo Finance· 1 year agoPlus Therapeutics, Inc. (Nasdaq: PSTV) specializes in targeted radiation treatments Rather than...
Q4 2023 Plus Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Marc Hedrick; President & CEO; Plus Therapeutics, Inc. Andrew Sims; VP & CFO; Plus Therapeutics, Inc. Norman LaFrance; SVP & Chief Medical Officer; Plus Therapeutics, Inc. Justin ...
